End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
15.55 CNY | -1.77% | -0.58% | +1.04% |
Apr. 17 | Apeloa Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 10 | Apeloa Pharmaceutical Co.,Ltd Approves Cash Dividend for 2023 | CI |
Sales 2024 * | 12.79B 1.77B | Sales 2025 * | 14.78B 2.05B | Capitalization | 18.18B 2.52B |
---|---|---|---|---|---|
Net income 2024 * | 1.23B 170M | Net income 2025 * | 1.59B 220M | EV / Sales 2024 * | 1.42 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.23 x |
P/E ratio 2024 * |
14.9
x | P/E ratio 2025 * |
11.5
x | Employees | 7,208 |
Yield 2024 * |
2.27% | Yield 2025 * |
3.05% | Free-Float | 47.03% |
1 day | -1.77% | ||
1 week | -0.58% | ||
Current month | +10.21% | ||
1 month | +20.54% | ||
3 months | +15.19% | ||
6 months | -6.44% | ||
Current year | +1.04% |
Managers | Title | Age | Since |
---|---|---|---|
Xin Liang Xu
CEO | Chief Executive Officer | 55 | 20-01-01 |
Jin Hui Zhang
DFI | Director of Finance/CFO | 49 | 19-03-06 |
Fang Meng Zhu
CHM | Chairman | 52 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Wen Cai Xu
BRD | Director/Board Member | 58 | 05-04-14 |
Ling Chen
BRD | Director/Board Member | 58 | 20-04-07 |
Xiang Quan Ge
BRD | Director/Board Member | 50 | 23-04-17 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.44% | 2 M€ | -12.23% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 15.55 | -1.77% | 14,339,210 |
24-05-16 | 15.83 | +0.25% | 16,182,560 |
24-05-15 | 15.79 | +0.51% | 16,118,200 |
24-05-14 | 15.71 | +2.35% | 18,789,620 |
24-05-13 | 15.35 | -1.85% | 22,776,980 |
End-of-day quote Shenzhen S.E., May 16, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+1.04% | 2.52B | |
+32.09% | 693B | |
+29.39% | 584B | |
-1.34% | 372B | |
+20.34% | 332B | |
+7.39% | 294B | |
+14.25% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+8.49% | 168B |
- Stock Market
- Equities
- 000739 Stock